« Previous
Next »
International Journal of Radiation Oncology * Biology * Physics
Volume 71, Issue 2
, Pages 362-370
, 1 June 2008
Adjuvant Radiotherapy and Survival for Patients With Node-Positive Head and Neck Cancer: An Analysis by Primary Site and Nodal Stage
References
- Head and neck cancer. N Engl J Med. 1993;328:184–194
- Neck dissection with and without radiotherapy: Prognostic factors, patterns of recurrence, and survival. Am J Surg. 1986;152:456–463
- . Textbook of radiotherapy. 3d ed.. Philadelphia: Lea & Febiger; 1980;
- . Postoperative irradiation for squamous cell carcinomas of the head and neck: Analysis of time–dose factors related to control above the clavicles. Int J Radiat Oncol Biol Phys. 1979;5:1943–1949
- Management of cervical lymph node metastases in squamous cell carcinoma of the tonsillar fossa, base of tongue, supraglottic larynx, and hypopharynx. Am J Surg. 1972;124:462–467
- Postoperative radiotherapy in head and neck carcinoma with extracapsular lymph node extension and/or positive resection margins: A comparative study. Int J Radiat Oncol Biol Phys. 1992;23:737–742
- Combined neck dissection and postoperative radiation therapy in the management of the high-risk neck: A matched-pair analysis. Int J Radiat Oncol Biol Phys. 1998;40:529–534
- . Management of head and neck cancer: A multidisciplinary approach. 2nd ed.. Philadelphia: Lippincott; 1994;
- Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;51:571–578
- Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709–720
- Evaluation of the dose for postoperative radiation therapy of head and neck cancer: First report of a prospective randomized trial. Int J Radiat Oncol Biol Phys. 1993;26:3–11
- Postoperative radiotherapy for stage II or III non–small-cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol. 2006;24:2998–3006
- Surveillance, Epidemiology, and End Results (SEER) Program Public-Use Data (1973–1999), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. Available at: http://seer.cancer.gov/publicdata/. Accessed November 11, 2006.
- Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma. JAMA. 2006;295:389–397
- . International classification of diseases for oncology. 2nd ed.. Geneva, Switzerland: World Health Organization; 1990;
- . Clinical Practice Guidelines in Oncology: Head and Neck Cancer. V. I. Jenkintown, PA: National Comprehensive Cancer Network; 2006;
- . Squamous cell carcinoma of the head and neck treated with radiation therapy: The role of neck dissection for clinically positive neck nodes. Int J Radiat Oncol Biol Phys. 1986;12:733–740
- Elective and therapeutic selective neck dissection. Oral Oncol. 2006;42:14–25
- Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma—the University of Iowa experience. Int J Radiat Oncol Biol Phys. 2005;63:410–421
- Local control of carcinoma of the tonsil by radiation therapy: An analysis of patterns of fractionation in nine institutions. Int J Radiat Oncol Biol Phys. 1995;33:549–562
- Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350:1945–1952
- Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350:1937–1944
- Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356:1944–1956
- Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006;354:567–578
- Hyperfractionated or accelerated radiotherapy in head and neck cancer: A meta-analysis. Lancet. 2006;368:843–854
- Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med. 1998;338:1798–1804
- . Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: A subset analysis of the Head and Neck Contracts Program. J Clin Oncol. 1990;8:838–847
- Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys. 1992;23:705–713
- Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck. 2005;27:843–850
- Integration of gefitinib (G), into a concurrent chemoradiation (CRT) regimen followed by G adjuvant therapy in patients with locally advanced head and neck cancer (HNC)—a phase II trial. Proc Am Soc Clin Oncol. 2005;23(Suppl):5506a
- Head and neck cancer. N Engl J Med. 2001;345:1890–1900
- Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: Curative and organ-preserving therapy for advanced head and neck cancer. J Clin Oncol. 2003;21:320–326
- Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2003;55:312–321
- Reirradiation of recurrent and second primary head and neck malignancies: A comprehensive review. Cancer Treat Rev. 2003;29:21–30
- Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: Preliminary experience and future directions. Int J Oncol. 2006;28:1141–1151
Conflict of interest: none.
PII: S0360-3016(07)04444-6
doi: 10.1016/j.ijrobp.2007.09.058
© 2008 Elsevier Inc. All rights reserved.
« Previous
Next »
International Journal of Radiation Oncology * Biology * Physics
Volume 71, Issue 2
, Pages 362-370
, 1 June 2008
